ArticleACS omega2019
Cobalt Phthalocyanine-Sensitized Graphene-ZnO Composite: An Efficient Near-Infrared-Active Photothermal Agent.
Article in ACS omega, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- A stimuli-responsive porous carbon nanovehicle for light-initiating and thermo-driving phototheranostics of renal cell carcinoma.iScience · 2026Article
- Boosting Photocatalytic Activity in Rhodamine B Degradation Using Cu-Doped ZnO Nanoflakes.ACS omega · 2025Article
- By-product distribution and cytotoxicity assessment of ZnO-assisted photocatalytic degradation of reactive blue 250 dye.Heliyon · 2024Article
- Macrocyclic Compounds: Metal Oxide Particles Nanocomposite Thin Films Deposited by MAPLE.Materials (Basel, Switzerland) · 2023Article
- The Cytotoxicity of Carbon Nanotubes and Hydroxyapatite, and Graphene and Hydroxyapatite Nanocomposites against Breast Cancer Cells.Nanomaterials (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Herein, a promising near-infrared-responsive photothermal agent was designed by anchoring of rice grain-shaped ZnO particles over graphene (GR) nanosheets and subsequent sensitization with cobalt phthalocyanine (CoPc). Thus, produced GR-ZnO-CoPc was able to attain the temperature of 68 °C by irradiating to 980 nm laser for 7 min, which is extremely higher than the endurance temperature of cancer cells. The linear fashioned progression in the photothermal effect of GR nanosheets was conquered by immobilization of ZnO particles and successive sensitization with CoPc. The excellence found in the photothermal effect of GR-ZnO-CoPc was verified by estimation of its photothermal conversion efficiency. The photothermal conversion efficiency assessed for GR-ZnO-CoPc was higher than those for the popular gold- and CuS-based photothermal agents. In addition, it possessed significant stability against photobleaching and structural rupture. It was found that the photothermal effect of GR-ZnO-CoPc is proportional to its concentration. However, by replacement of a 980 nm laser system with 808 nm, the photothermal effect of GR-ZnO-CoPc was reduced, which could be due to lower absorption of GR-ZnO-CoPc at 808 nm compared to 980 nm. On account of its significance and important properties, GR-ZnO-CoPc could be an interesting photothermal agent to employ in future photothermal therapy for cancer.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.